- Home
- HOTH vs SVRN Comparison
HOTH vs SVRN Comparison
Compare HOTH & SVRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOTH | SVRN |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | Greece |
| Employees | N/A | 87 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 12.9M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOTH | SVRN |
|---|---|---|
| Price | $0.65 | $5.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 395.0K | 7.7K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $0.16 |
| 52 Week High | $2.12 | $12.48 |
Technical Indicators
Market Signals| Indicator | HOTH | SVRN |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 33.54 |
| Support Level | $0.49 | $0.26 |
| Resistance Level | $0.80 | $8.99 |
| Average True Range (ATR) | 0.04 | 0.69 |
| MACD | -0.00 | -0.51 |
| Stochastic Oscillator | 11.82 | 4.63 |
Price Performance
Historical ComparisonAbout HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.
About SVRN OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.